GLP-1 metabolite GLP-1(9 –36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Conclusions/interpretationWe conclude that the GLP-1 metabolite GLP-1(9 –36) is a systemic inhibitor of glucagon secretion. We propose that the increase in circulating glucagon observed following genetic/pharmacological inactivation of glucagon signalling in mice and in people with type 2 diabetes reflects the removal of GLP-1(9–36)’s glucagonostatic action.Graphical Abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Genetics | Insulin | Pancreas | Physiology | Study